Epigenetic changes, such as DNA methylation and histone modification, can turn genes on or off without altering the DNA sequence. Targeting these modifications can reactivate tumor suppressor genes or silence oncogenes. Drugs like azacitidine and vorinostat target these epigenetic changes and are used in certain blood cancers.
